Trials / Conditions / Human Immunodeficiency Virus

Human Immunodeficiency Virus

326 registered clinical trials studyying Human Immunodeficiency Virus — 30 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Medical Mistrust Among Hispanic/Latino Gay, Bisexual and Other Men Who Have Sex With Men (HLMSM) NCT06132672	Wake Forest University Health Sciences	N/A
Recruiting	HIV Therapeutic DNA Vaccine (ICVAX) Phase I Clinical Trial in Hong Kong NCT07530198	Immuno Cure Holding (HK) Limited	Phase 1
Recruiting	Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People With HIV Receiving An NCT06819176	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 1
Recruiting	Universal Test and Connect for HIV Service Delivery in South Africa NCT06408142	Johns Hopkins University	—
Recruiting	The Eswatini PRISM Study on Adolescents Living With HIV NCT07101458	Eswatini Nazarene Health Institutions	N/A
Recruiting	The SUSTAIN 2 Study - SUStained HIV Treatment for Adherence After Interruption in Care NCT06554223	Brigham and Women's Hospital	N/A
Not Yet Recruiting	Use of ACU-D1 in HPV Associated Vulvar and Perianal Lesions in People With HIV NCT06233331	Emory University	Phase 1
Not Yet Recruiting	Impact of NMN Supplementation on CD4+ T Cell Recovery in HIV Patients With Immunological Failure NCT06889142	TriHealth Inc.	N/A
Active Not Recruiting	Feasibility of Intravaginal Artesunate as Adjuvant HPV & Cervical Precancer Treatment in Kenya NCT06519994	UNC Lineberger Comprehensive Cancer Center	Phase 2
Recruiting	Use of Long-Acting Injectable Cabotegravir/Rilpivirine for the Treatment of HIV in Belgium NCT06424964	Belgian Research on AIDS and HIV Consortium	—
Completed	Anal High-risk HPV, HSIL, and Microbiome Among Hispanic Peoples Living With HIV (PLWH) NCT06651957	University of California, San Francisco	—
Not Yet Recruiting	Computerized Cognitive Rehabilitation of Patients With Cognitive Deficits Due to the Human Immunodeficiency Vi NCT06603727	Centre Hospitalier Universitaire Vaudois	N/A
Recruiting	Integrated Mental Health Care for Pregnant Women With HIV in Kenya: The Tunawiri Study NCT06117163	University of Colorado, Denver	N/A
Enrolling By Invitation	Data Science and Qualitative Research for Decision Support in the HIV Care Cascade NCT06604663	Brown University	N/A
Completed	IMB-guided Intervention to Encourage PrEP Uptake Among Young Men Who Have Sex With Men NCT04865341	Medical College of Wisconsin	N/A
Recruiting	Gut Microbiota-Mediated Inflammatory Interactions Between AUD and HIV Infection NCT06139224	Rush University Medical Center	N/A
Not Yet Recruiting	Human Immunodeficiency Virus Pre-exposure Prophylaxis Program in General Practice NCT06258876	Assistance Publique - Hôpitaux de Paris	—
Active Not Recruiting	Support for Adolescents Living With HIV in South Africa NCT06035445	Emory University	N/A
Recruiting	Evaluation of Safety and Immunogenicity of Ad26.Mos4.HIV and CH505 TF chTrimer Combination in Healthy Adults NCT06205056	U.S. Army Medical Research and Development Command	Phase 1
Withdrawn	Radiopaque Matrix MK-8591 Implant in Participants at Low-Risk for Human Immunodeficiency Virus Type 1 (HIV-1) NCT05115838	Merck Sharp & Dohme LLC	Phase 2
Recruiting	V+PSF-M for Tobacco Cessation in HIV Care in India NCT05786547	University of Colorado, Denver	Phase 3
Not Yet Recruiting	Gut Microbiome in People Living With HIV and HBV NCT06130137	Kangbuk Samsung Hospital	—
Recruiting	Characteristics and Outcomes of TB and HIV Co-infections NCT06531772	Assiut University	—
Unknown	A Pragmatic Trial With Optimized Dose of Rifampicin and Moxifloxacin for the Treatment of Drug Susceptible Pul NCT05575518	Stellah Mpagama	Phase 3
Recruiting	A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIV NCT05495906	University of British Columbia	Phase 4
Active Not Recruiting	Delivery Optimization for Pre-Exposure Prophylaxis (DO PrEP) Study NCT06176859	Massachusetts General Hospital	N/A
Recruiting	Project Khanya: Peer-Delivered Intervention to Improve HIV Medication Adherence and Substance Use in South Afr NCT05933226	University of Maryland, College Park	N/A
Completed	Evaluation of Problem Management Plus in Pregnant Women With HIV in Kenya NCT05841797	University of Colorado, Denver	N/A
Active Not Recruiting	A Real-life Study of the Use of Cabotegravir Plus Rilpivirine Long-acting in ART-experienced Pre-treated Peopl NCT06518408	University Hospital Virgen de las Nieves	—
Recruiting	Baricitinib for Reduction of HIV - CNS NCT05452564	William Tyor	Phase 2
Recruiting	Low Dose Naltrexone for Pain in Patients With HIV NCT05537935	Emory University	Phase 4
Terminated	Antiretroviral Improvement Among Medicaid Enrollees NCT05477485	Virginia Commonwealth University	N/A
Unknown	The Prevalence of Oral HPV Infection and Oral Lesions in People Living With HIV NCT06205511	Vivent Health	—
Completed	First in Human Study of TLC-ART 101 (ACTU 2001) NCT05850728	University of Washington	Phase 1
Completed	HIV Education Kit for Adolescents (Pencegahan HIV di Kalangan Remaja), PREM-Kit NCT05623800	Universiti Teknologi Mara	N/A
Completed	Acceptability and Feasibility of Combination Treatment for Cervical Precancer Among South African Women Living NCT05413811	UNC Lineberger Comprehensive Cancer Center	N/A
Recruiting	Text Education About Cardiovascular Health and HIV (TEACH-HIV) NCT05642858	University of California, San Francisco	N/A
Completed	ICVAX as a HIV Therapeutic DNA Vaccine NCT06253533	Immuno Cure Holding (HK) Limited	Phase 1
Terminated	Efficacy, Tolerability and Acceptability of Biktarvy by TPLWH NCT04944654	Chelsea and Westminster NHS Foundation Trust	Phase 4
Withdrawn	A Safety Study of Brentuximab Vedotin in Participants With HIV NCT05244473	Seagen Inc.	Phase 1
Completed	3BNC117-LS and 10-1074-LS Plus N-803 (bNAb+N-803) NCT05245292	Rockefeller University	Phase 1
Completed	The OPENS Trial: Offering Women PrEP (Aim 2) NCT05619497	University of California, San Francisco	N/A
Recruiting	Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV NCT05266898	Louisiana State University Health Sciences Center in New Orleans	Phase 4
Completed	MK-8527 Single-Dose Trial in HIV-1 Infected Participants (MK-8527-004) NCT05494736	Merck Sharp & Dohme LLC	Phase 1
Completed	The Effect of Yoga for Stress Among HIV Patients in Indonesia NCT05503680	National Taipei University of Nursing and Health Sciences	N/A
Withdrawn	Doravirine and Weight Gain in Antiretroviral Naive NCT05457530	Prism Health North Texas	Phase 3
Active Not Recruiting	A Savings Intervention to Reduce Men's Engagement in HIV Risk Behaviors NCT05385484	University of Pennsylvania	N/A
Completed	Pharmacy-based Pre-exposure Prophylaxis NCT04393935	Emory University	N/A
Unknown	The Positively Dance Pilot Program for Women Living With HIV NCT05295797	University of British Columbia	N/A
Completed	Effect of Aerobic Training and Ginkgo Biloba on Lipids Levels in HIV-positive Patients Undergoing Antiretrovir NCT06403787	University of Guadalajara	Phase 2 / Phase 3
Active Not Recruiting	Simunye: A Couples-focused Intervention for HIV Prevention and Care in South Africa NCT05231707	University of Michigan	N/A
Recruiting	Harm Reduction in HIV Primary Care for PLWH Who Use Drugs NCT05404750	University of Pittsburgh	—
Withdrawn	Combined Injectable Treatment for HIV and OUD NCT05991622	Rhode Island Hospital	Phase 2
Unknown	Study of Entry and Continuation in Care for People Living With HIV in French Guiana NCT05354934	Centre Hospitalier de Cayenne	—
Unknown	The Impact Evaluation of the COVID-19 Prevention on Risk Factors of HIV and Sexually Transmitted Comorbidity NCT05188456	National Taiwan University	—
Completed	Evaluating Drug Interactions Between Doravirine With Estradiol and Spironolactone in Healthy Transgender Women NCT04283656	Thomas Jefferson University	Phase 1
Recruiting	Tulane Abdominal Transplant Institute (TATI) of Solid Organ Transplantation of HIV-Positive Recipients From HI NCT05159466	Tulane University	—
Completed	HPV Vaccine Effectiveness Study in Rwandan Women Living With HIV NCT05247853	Montefiore Medical Center	—
Completed	Package of Resources for Assisted Contact Tracing: Implementation, Costs, and Effectiveness NCT05343390	University of North Carolina, Chapel Hill	N/A
Completed	Pilot Test of a Couple-Based Medication Adherence Intervention for HIV-Positive Women and Their Male Partners NCT03809364	University of Maryland, College Park	N/A
Completed	Peers Plus Mobile App for Treatment in HIV NCT05427318	San Diego State University	N/A
Unknown	Investigating the Interaction Between Two Long-acting Reversible Methods of Contraception and Dolutegravir, a NCT04910711	Botswana Harvard AIDS Institute Partnership	Phase 4
Completed	Pre-exposure Prophylaxis Implementation in Central-Eastern European Countries NCT05323123	Columbia University	N/A
Unknown	Switch to DOVATO in Patients Suppressed on Biktarvy (SOUND) NCT04826562	Saint Michael's Medical Center	Phase 4
Active Not Recruiting	Integration of Hypertension Management Into HIV Care in Nigeria NCT04704336	NYU Langone Health	N/A
Completed	Mitigating Sexual Stigma Within Healthcare Interactions Improve Engagement of MSM in HIV Prevention NCT04779736	Albert Einstein College of Medicine	N/A
Recruiting	Cefixime Clinical Trial NCT04958122	University of Southern California	Phase 3
Completed	Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in Men NCT04772469	University of California, San Francisco	N/A
Completed	Targeting HIV Retention and Improved Viral Load Through Engagement ('THRIVE') NCT04481373	Baylor College of Medicine	N/A
Completed	Acceptability, Feasibility and Impact of Oral HIV Self-testing for Partner Testing Among Kenyan Adolescent Gir NCT04805112	University of Pennsylvania	N/A
Completed	Safety and Immunogenicity of a Mycobacterium Tuberculosis Vaccine M72/AS01E in Participants With Well-controll NCT04556981	Gates Medical Research Institute	Phase 2
Completed	Linking Persons With HIV, Discharged From Jail, With Community Care NCT04560556	Emory University	—
Active Not Recruiting	Cross-disciplinary HIV Integrated Mental Health Support Intervention NCT04833829	Emory University	N/A
Completed	3BNC117-LS and 10-1074-LS in Viremic HIV-infected Individuals NCT04250636	Rockefeller University	Phase 1
Completed	Efficacy of BIC/F/TAF Versus Standard of Care in the Treatment of New HIV Infection Diagnoses in the Context o NCT04653194	Chelsea and Westminster NHS Foundation Trust	Phase 3
Completed	iTransition Development NCT04383223	Emory University	N/A
Completed	Incentives to Promote Sustained Linkage to HIV Care NCT04431154	University of Pennsylvania	N/A
Completed	Biomarkers for Event-driven PrEP Adherence NCT04298697	Emory University	Phase 4
Completed	Effectiveness of an Integrated Treatment to Address Smoking Cessation and Anxiety/ Depression in People Living NCT03904186	Massachusetts General Hospital	N/A
Completed	Adaptation of the Friendship Bench Intervention for HIV-infected Perinatal Women in Lilongwe NCT04143009	University of North Carolina, Chapel Hill	N/A
Completed	Mobile Evidence-Based Smoking Cessation for Veterans Living With HIV (MESH) NCT04135937	VA Office of Research and Development	Phase 4
Completed	Safety and Immunogenicity of a Tetravalent Dengue Vaccine in HIV-Positive Adults NCT02741128	Sanofi Pasteur, a Sanofi Company	Phase 2
Completed	Effects of Crofelemer on the Gut Microbiome in Healthy Volunteers and in HIV+ Patients With Non-Infectious Dia NCT04192487	Napo Pharmaceuticals, Inc.	Phase 4
Completed	Trans People Living With HIV Throughout Europe NCT03922269	Chelsea and Westminster NHS Foundation Trust	—
Completed	The Happy Older Latinos Are Active (HOLA) Health Promotion Study in HIV-Infected Latino Men NCT03839212	University of Miami	N/A
Completed	Thermocoagulation for Treatment of Precancerous Cervical Lesions NCT04191967	University of California, San Francisco	N/A
Terminated	Integrase Regimen Switch to Symtuza to Increase Tolerability/Adherence (SYMita) NCT04240210	Midland Research Group, Inc.	Phase 4
Completed	Usability Study of IeHS in Indonesia NCT04179344	Bekasi City Public Hospital	—
Unknown	Nucleosides And Darunavir/Dolutegravir In Africa NCT03988452	Makerere University	Phase 3
Completed	Health Information for Infected Veterans NCT03190317	VA Office of Research and Development	—
Completed	Pharmacokinetics of Plasma Doravirine Once Daily Over 72 Hours Following Drug Intake Cessation in Healthy Volu NCT03894124	Chelsea and Westminster NHS Foundation Trust	Phase 1
Completed	Plan and Pledge, HIV Self-testing in South Africa NCT03898557	University of Pennsylvania	N/A
Completed	Building Mobile HIV Prevention and Mental Health Support in Low-resource Settings NCT03912753	Columbia University	N/A
Completed	Medication Adherence and Outcomes Among Patients in United States With HIV NCT03995745	University of Pennsylvania	N/A
Terminated	Immunologic Response to Kansui in Treated HIV+ Individuals: a Dose Escalation Study NCT02531295	University of California, San Francisco	Phase 1
Completed	Doravirine, Rifapentine and Isoniazid Interaction NCT03886701	Walter K. Kraft	Phase 1
Completed	Testing Strategies for Couple Engagement in PMTCT and Family Health in Kenya NCT03547739	University of Alabama at Birmingham	N/A
Completed	A Study of MK-8527 in Human Immunodeficiency Type 1 Virus (HIV-1) Infected Participants (MK-8527-002) NCT03615183	Merck Sharp & Dohme LLC	Phase 1
Completed	Growth Hormone Dynamics and Cardiac Steatosis in HIV NCT03826160	Massachusetts General Hospital	—
Completed	Contributing Factors for Poor HIV Treatment Response in Children With TB/HIV Coinfection NCT03800407	University of Florida	—
Completed	Adequacy of the New Pediatric Isoniazid/Rifampin/Pyrazinamide (HRZ) Tablet NCT03800381	University of Florida	—
Active Not Recruiting	Increasing PrEP Use in High-Risk Social Networks of African-American MSM in Underserved Low-Risk Cities NCT03823209	Medical College of Wisconsin	N/A
Completed	Our Family Our Future: A Resilience-oriented Family Intervention to Prevent Adolescent HIV/STI Infection and D NCT03231358	Brown University	Phase 3
Completed	Project PRIDE (Promoting Resilience In Discriminatory Environments) NCT03528135	University of Houston	N/A
Completed	Development of a Health-Related Symptom Index for Participants With and Either Treated or Monitored for Anal H NCT04276935	AIDS Malignancy Consortium	—
Completed	Reaching Out to the UNdiagnosed People Infected With Blood Borne Viral Infections NCT04363411	Hasselt University	N/A
Completed	Active Hexose Correlated Compound in Tuberculosis-HIV (Human Immunodeficiency Virus) Infection NCT05100758	Hasanuddin University	N/A
Terminated	Using Social Media to Improve ART Retention and Treatment Outcomes Among YLHIV in Nigeria NCT03516318	FHI 360	N/A
Terminated	A Single Dose of Pembrolizumab in HIV-Infected People NCT03367754	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 1
Completed	Obstructive Sleep Apnea Endotypes and Impact on Phenotypes of People Living With HIV NCT03575143	University of California, San Diego	—
Terminated	Quantitative HPV Genotyping in Screening of Anal Intraepithelial Neoplasia in HIV-positive Patients NCT03742375	Universitaire Ziekenhuizen KU Leuven	N/A
Completed	Effectiveness & Implementation of a Behavioral Intervention for Adherence and Substance Use in HIV Care in Sou NCT03529409	University of Maryland, College Park	N/A
Completed	First-in-human Study of 10-1074-LS Alone and in Combination With 3BNC117-LS NCT03554408	Rockefeller University	Phase 1
Completed	3BNC117 and 10-1074 in ART-treated Individuals NCT03526848	Rockefeller University	Phase 1
Terminated	2-5 Intermittent Caloric Restriction in HIV NCT03489109	National Institute of Allergy and Infectious Diseases (NIAID)	N/A
Completed	Effect of Evolocumab on Coronary Endothelial Function NCT03500302	Johns Hopkins University	Phase 2
Completed	A Study of 2 Different Regimens of Tetravalent Ad26.Mos4.HIV Prime Followed by Boost With Modified Vaccinia An NCT03307915	Janssen Vaccines & Prevention B.V.	Phase 1
Completed	Efficacy, Safety & Tolerability of Switching EFV/TDF/FTC to BIC/FTC/TAF in Virologically Suppressed Adults Wit NCT03502005	Midland Research Group, Inc.	Phase 4
Completed	123I Radiolabeled 3BNC117 NCT03468582	University of Lausanne Hospitals	EARLY_Phase 1
Completed	Impact of Integrated HIV/NCD Screening on HIV Testing Uptake and Engagement in HIV Care in Kisarawe, Tanzania NCT03098654	Medical University of South Carolina	N/A
Completed	Effect of High Dose Vitamin D Supplementation on HIV Latency NCT03426592	University of Melbourne	Phase 2
Completed	Mobile Messaging Intervention to Present New HIV Prevention Options for Men Who Have Sex With Men (MSM) NCT03666247	Emory University	N/A
Completed	Computer-based Intervention for Alcohol-using HIV/HCV+ Women NCT03362476	New York University	N/A
Recruiting	Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune NCT03300830	National Cancer Institute (NCI)	—
Completed	Partners-based HIV Treatment for Couples Attending Antenatal Care NCT03149237	Vanderbilt University Medical Center	N/A
Completed	Clinical Trial of HIV Vaccine Combinations in Healthy Men and Women NCT03408262	Imperial College London	Phase 1
Completed	3BNC117-LS First-in-Human Phase 1 Study NCT03254277	Rockefeller University	Phase 1
Completed	Effectiveness of Booster With 1 or 2 Doses of HAV Vaccine Among HIV-infected Patients NCT03855176	National Taiwan University Hospital	Phase 4
Terminated	Impact of Hepatitis C Therapy and Bone Health NCT03221582	Dallas VA Medical Center	Phase 4
Completed	Prevention and Treatment Continuum for Youth at HIV Risk, Acutely Infected and With Established HIV Infection NCT03205696	University of California, Los Angeles	—
Completed	Inflammasome Activation Via Circulating Metabolites NCT03191175	University Hospital, Bordeaux	—
Completed	A Combination HIV Prevention Strategy for Young Women at Risk for HIV NCT03235518	Columbia University	—
Completed	MAMAS: Mentoring Adolescent Mothers at School NCT03090802	Drexel University	N/A
Completed	Social Network Intervention to Engage Community PLH to Engage in HIV Medical Care NCT03157258	Medical College of Wisconsin	N/A
Completed	Secondary Distribution of HIV Self-tests: an Innovative Strategy for Promoting Partner Testing and Reducing HI NCT03135067	University of Pennsylvania	N/A
Completed	Maraviroc Efficacy for Hepatitis C NCT02881762	University of Maryland, Baltimore	Phase 4
Not Yet Recruiting	Feasibility of an Ingestible Sensor System to Measure PrEP Adherence in YMSM NCT02891720	Hektoen Institute for Medical Research	N/A
Completed	Positive Attitudes Concerning Infant Feeding- a Questionnaire for Women Living With HIV NCT03294499	Imperial College London	—
Completed	Impact of Representative Payee Services on ART Adherence Among Marginalized People Living With HIV/AIDS NCT03561103	University of Pittsburgh	N/A
Completed	CBSM Intervention Via mHealth to Ameliorate HIV-related Fatigue NCT03149094	Medical University of South Carolina	N/A
Completed	Increasing Uptake of Evidence-Based Screening Services Through CHW-led Multi-modality Intervention NCT02970136	University of Miami	N/A
Completed	BRIDGE: Improving HIV Service Delivery for People Who Inject Drugs NCT02796027	Columbia University	N/A
Active Not Recruiting	Impact of HIV-1 and Aging on Mucosal Vaccine Responses NCT03729778	VA Eastern Colorado Health Care System	EARLY_Phase 1
Completed	Sofosbuvir and Daclatasvir for Treating Hepatitis C in 200 Patients Co-infected With Human Immunodeficiency Vi NCT03369327	Tehran University of Medical Sciences	Phase 3
Completed	Trauma Intervention for Affect Regulation, AIDS, and Substances NCT02923141	University of Miami	N/A
Completed	Impact of Recombinant Human Growth Hormone on HIV Persistence NCT03091374	McGill University Health Centre/Research Institute of the McGill University Health Centre	Phase 2
Completed	Innovations in HIV Testing NCT03162965	University of North Carolina, Chapel Hill	N/A
Completed	Rapid HIV Treatment Initiation, Access and Engagement in Care NCT03512964	Johns Hopkins University	N/A
Terminated	Study of the Safety, Tolerability and Pharmacokinetics of TMB-607 in HIV-Negative Volunteers NCT03110549	TaiMed Biologics Inc.	Phase 1
Completed	Support for Perinatal Adherence and Depression NCT03069417	Massachusetts General Hospital	N/A
Completed	Digital Star: HIV Prevention for Youth in Mental Health Treatment NCT02921841	Rhode Island Hospital	N/A
Terminated	Triumeq As an Integrase Single Tablet Regimen in People With HIV Who Inject Drugs NCT02659761	University College Dublin	Phase 4
Completed	Optimizing Retention in Care and Adherence to Anti-retroviral Therapy Amongst Adolescents Living With HIV in R NCT04531605	Youth Development Labs, Inc dba YLabs	N/A
Unknown	Safety and Efficacy of Allogenic Adoptive Immune Therapy for Immune Reconstitution in Chronic HIV-1 Infected P NCT02648516	Beijing 302 Hospital	Phase 1 / Phase 2
Completed	Safety and Efficacy Study of Vaccine Schedule With Ad26.Mos.HIV and MVA-Mosaic in Human Immunodeficiency Virus NCT02919306	Janssen Vaccines & Prevention B.V.	Phase 1 / Phase 2
Completed	Intervention to Encourage HIV Testing and Counseling Among Adolescents NCT02812329	Yale University	Phase 1
Completed	Improving Outcomes in HIV Patients Using Mobile Phone Based Interactive Software Support NCT02953080	Makerere University	N/A
Completed	Generic VEL/SOF With or Without RBV for HIV/HCV Coinfected Patients NCT03250910	National Taiwan University Hospital	Phase 4
Completed	Supporting Adolescents to Adhere - an Intervention Using Airtime Rewards Allocated by a Prize Drawing NCT02918838	RAND	N/A
Completed	Cooperative Re-Engagement Controlled Trial (CoRECT) NCT02693145	Centers for Disease Control and Prevention	N/A
Completed	A Multidisciplinary "Integrated Management Team to Improve Maternal-Child Outcomes (IMPROVE)" Intervention to NCT04598958	Elizabeth Glaser Pediatric AIDS Foundation	N/A
Completed	Study in HIV1-Positive, Virosuppressed Patients Currently inTreatment With Ritonavir-Boosted Protease Inhibito NCT02926456	Janssen-Cilag S.p.A.	—
Completed	Trial to Assess the Continued Safety of and Adherence to a Vaginal Ring Containing Dapivirine in Women NCT02858037	International Partnership for Microbicides, Inc.	Phase 3
Completed	Contextualizing & Responding to HIV Risk Behaviors NCT03300908	Columbia University	N/A
Completed	Positive Connections: COPA2 NCT02846350	University of Miami	N/A
Completed	Non Invasive Oral Cancer Screening Among HIV Infected Individuals NCT02823847	M.D. Anderson Cancer Center	EARLY_Phase 1
Completed	3BNC117 and 10-1074 in HIV Uninfected Adults NCT02824536	Rockefeller University	Phase 1
Completed	A Pilot Study of MONOtherapy of DOlutegravir in HIV-1 Virologically Suppressed Patients NCT02572947	Calmy Alexandra	Phase 2
Completed	HIV & Drug Abuse Prevention for South African Men NCT02358226	University of California, Los Angeles	Phase 3
Completed	Friends for Life Circles for Option B Plus NCT02515370	MU-JHU CARE	N/A
Completed	HIV Drug Switch Followed by HCV Therapy in HIV-HCV Co-Infection NCT02660905	Ottawa Hospital Research Institute	Phase 3
Completed	'HI-4-TU' Study: Health Improvement for Teen Ugandans Study NCT02845284	Johns Hopkins University	N/A
Completed	Addressing Psychosocial Comorbidities in HIV Treatment and Prevention NCT02696681	University of Miami	N/A
Completed	Cognitive-Based Compassion Training (CBCT) for People Living With HIV (PLHIV) NCT02395289	Emory University	N/A
Completed	Dutch Acute HCV in HIV Study (DAHHS-2): Grazoprevir/Elbasvir for Acute HCV NCT02600325	Erasmus Medical Center	Phase 3
Completed	Impact of ART Adherence on HIV Persistence and Inflammation NCT02797093	University of Colorado, Denver	—
Completed	Impact of Hepatitis C Virus Therapy on Central Nervous System Outcomes NCT02650024	University of California, San Diego	—
Completed	Improving Prognosis in HIV Infection NCT02640625	Oslo University Hospital	Phase 1 / Phase 2
Completed	The Compartmental Biology of HIV in the Male Genital Tract NCT02638493	University of North Carolina, Chapel Hill	—
Completed	Inflammatory Pathogenesis of Coronary Atherosclerosis in HIV NCT02624180	Johns Hopkins University	Phase 2
Completed	Simplification From Tenofovir Plus Lamivudine or Emtricitabine Plus Ritonavir-Boosted-Protease Inhibitor to Ri NCT02652793	Judit Pich	N/A
Completed	Innovations in HIV Testing (TI) NCT03271424	University of North Carolina, Chapel Hill	N/A
Withdrawn	Safety and Acceptability of Cabotegravir in HIV Uninfected Women in KwaZulu-Natal, South Africa NCT02462772	Centre for the AIDS Programme of Research in South Africa	Phase 2
Completed	Impact of Valganciclovir on Severe IRIS-Kaposi Sarcoma Mortality: an Open-label, Parallel, Randomized Controll NCT03296553	National Institute of Cancerología	Phase 2
Active Not Recruiting	Liver Fibrosis in Zambian HIV-HBV Co-infected Patients NCT02344680	University of Alabama at Birmingham	—
Completed	A Non-inferiority Randomized Controlled Trial to Evaluate Promoting Condom Use Among MSM and Transgender Indiv NCT02516930	University of North Carolina, Chapel Hill	N/A
Completed	Safety and Efficacy of Allogenic Adoptive Immune Therapy for Advanced AIDS Patients NCT02651376	Beijing 302 Hospital	Phase 1 / Phase 2
Completed	CHAMPS Study: Chronic HepAtitis C Management to ImProve OutcomeS NCT02402218	Johns Hopkins University	N/A
Completed	SMS as an Incentive To Adhere (SITA) - An Intervention Communicating Social Norms by SMS to Improve ARV Adhere NCT02514356	RAND	N/A
Terminated	Accuracy of Portable Colposcopy and HPV Genotypes Among HIV+ Women NCT02338141	Duke University	N/A
Recruiting	Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus NCT02479698	M.D. Anderson Cancer Center	Phase 2
Completed	Bringing South African Men Into HIV Counseling and Testing and Care NCT03794245	University of California, Los Angeles	N/A
Completed	Clinical Evaluation of the Xpert® HIV-1 VL NCT02461576	Cepheid	—
Completed	Feasibility of Short-Term PrEP Uptake for MSM With Episodic High-Risk for HIV NCT02495779	James Egan	N/A
Unknown	Prospective Evaluation of HIV Patients Using Non-invasive Methods for Estimation of Liver Fibrosis and Steatos NCT02542020	Oswaldo Cruz Foundation	—
Completed	Factors Associated With Late HIV Diagnosis in Grampian: an Epidemiological Study NCT02804724	University of Aberdeen	—
Completed	Randomized Controlled Trial of Shang Ring Male Children Circumcision: Comparison Between Flip and No Flip Tech NCT02481492	Ningbo No. 1 Hospital	N/A
Completed	Long Term Follow-up of HPV Vaccine in HIV (CTN 236) NCT06915779	University of British Columbia	—
Completed	ART Readiness in HIV-infected Pregnant Women NCT02459678	University of North Carolina, Chapel Hill	N/A
Completed	Impact of Pre-ART Blood CD4+ T Cell Level on the Rectal Reservoir in Long-term HIV-1 Treated Men NCT02526940	Centre Hospitalier Universitaire de Saint Etienne	—
Completed	Simplifying the Shang Ring Technique for Circumcision of Men and Boys NCT02390310	EngenderHealth	N/A
Unknown	Validation of Rapid Tests for the Serological Diagnosis of HIV in 9 to 24 Months Old Children NCT03984552	The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)	—
Completed	The Dolutegravir Antiretroviral Mono-Therapy for HIV Trial NCT02401828	Erasmus Medical Center	Phase 4
Completed	Community Home-based Care Intervention and Its Health Outcome in HIV-positive People NCT03505866	Integrated Development Foundation Nepal	N/A
Completed	Pharmacokinetics of Once Daily Darunavir/Ritonavir in HIV-infected Children NCT02285478	Radboud University Medical Center	—
Completed	Pharmacokinetic Study of the Dapivirine Vaginal Ring in Lactating Women NCT02808949	International Partnership for Microbicides, Inc.	Phase 1
Completed	Reducing the Burden of Malaria in HIV-Infected Pregnant Women and Their HIV-Exposed Children (PROMOTE-BC2) NCT02282293	University of California, San Francisco	Phase 3
Terminated	An Extension of Protocol PRO 140_CD01 Study NCT02355184	CytoDyn, Inc.	Phase 2
Completed	Feasibility of Telerehabilitation in HIV-patients NCT03335176	Cliniques universitaires Saint-Luc- Université Catholique de Louvain	N/A
Completed	PRe-Exposure Prophylaxis Acceptability & Readiness Assessments for Toronto gaY, Bisexual and Other Men Who Hav NCT02149888	Unity Health Toronto	Phase 4
Completed	Comparison of Virologic and Immunologic Responses to Raltegravir and Dolutegravir in the Gastrointestinal Trac NCT02218320	University of North Carolina, Chapel Hill	—
Completed	DRV/r + RPV QD: Efficacy and Toxicity Reduction NCT01792570	ASST Fatebenefratelli Sacco	Phase 3
Unknown	HIV Medication Adherence in Underserved Populations NCT02392884	Cedars-Sinai Medical Center	N/A
Completed	The Tolerability of, and Adherence to, Dolutegravir With Co-formulated Tenofovir-emtricitabine for HIV Non-occ NCT02211690	Andrew Carr	Phase 4
Completed	Economic and Social Empowerment To Increase Upwards Mobility Among Women NCT02266108	University of California, San Diego	N/A
Completed	Jamii Bora: A Home-Based Couples Intervention NCT02403583	University of Alabama at Birmingham	N/A
Completed	DVD-based HIV/HCV Prevention Intervention for Drug-Involved Latino Criminal Justice Clients NCT02116179	University of Delaware	N/A
Completed	Study of Dapivirine Vaginal Ring (VR) in Adolescents NCT02028338	International Partnership for Microbicides, Inc.	Phase 2
Completed	HIV, Buprenorphine, and the Criminal Justice System (STRIDE2) NCT03583138	Yale University	—
Completed	Music for Health Project NCT01786148	Emory University	N/A
Completed	Relationship of Tenofovir With HIV-1 Suppression in ex Vivo Tissue in Adolescents NCT02134431	University of California, Los Angeles	—
Completed	Mother and Infant Visit Adherence and Treatment Engagement Study NCT02491177	University of Colorado, Denver	N/A
Completed	Elite Controller and ART-treated HIV+ Statin Versus ASA Treatment Intervention Study NCT02081638	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 2
Completed	Treatment Substitution With PRO 140 Monotherapy in Adult Subjects With HIV-1 Infection NCT02175680	CytoDyn, Inc.	Phase 2
Completed	Atazanavir/r + Lamivudine Dual Therapy NCT01599364	Catholic University of the Sacred Heart	Phase 4
Completed	HBV-HIV Coinfection Research Network NCT01924455	Virginia Commonwealth University	—
Completed	Effect of Cenicriviroc on HIV Neurocognitive Impairment NCT02128828	University of Hawaii	Phase 2
Completed	Medication Adherence in Human Immunodeficiency Virus (HIV) NCT02119390	St. Jude Children's Research Hospital	N/A
Completed	Study of People With HIV Infection Who Have High Viral Loads Despite Combination Antiretroviral Therapy NCT01976715	National Institute of Allergy and Infectious Diseases (NIAID)	—
Completed	Safety and Pharmacokinetics of Dapivirine Vaginal Ring in Post-menopausal Women NCT02010593	International Partnership for Microbicides, Inc.	Phase 2
Completed	Observational Study of HIV-associated Neurocognitive Disorder NCT01966094	Emory University	—
Completed	Short-term Disulfiram Administration to Reverse Latent HIV Infection: a Dose Escalation Study NCT01944371	University of California, San Francisco	Phase 1 / Phase 2
Completed	CARE Corrections: Technology for Jail HIV/HCV Testing, Linkage, and Care (TLC) NCT01721226	George Washington University	N/A
Completed	Dutch Acute HCV in HIV Study (DAHHS) NCT01912495	Erasmus Medical Center	Phase 2
Completed	A Trial to Assess the Functionality of Female Condom With a Silicone Elastomer Vaginal Ring NCT01755754	International Partnership for Microbicides, Inc.	Phase 1
Completed	Use of the Shang Ring Circumcision Device in Boys Below 18 Years Old in Kenya NCT01891409	EngenderHealth	N/A
Completed	Reduction of EArly mortaLITY in HIV-infected Adults and Children Starting Antiretroviral Therapy NCT01825031	Anna Griffiths, MRC	Phase 3
Completed	Opioid Relapse & HIV Risk: 48 Versus 24 Weeks of Injectable Extended Release Naltrexone NCT01882361	University of Pennsylvania	Phase 2 / Phase 3
Completed	Gonadal Function in Young to Middle Aged HIV-infected Men NCT03747003	Azienda Ospedaliero-Universitaria di Modena	—
Completed	Immunogenicity and Safety of Trivalent Influenza Vaccine in Non-pregnant HIV-infected Women NCT01812980	University of Witwatersrand, South Africa	Phase 4
Completed	HIV Non-Occupational Post-Exposure Prophylaxis NCT01855867	Kenneth H. Mayer, MD	Phase 4
Completed	Adipose Tissue and Immune Activation in HIV NCT04439448	Vanderbilt University Medical Center	—
Completed	Safety Study of a Dual Anti-HIV Gene Transfer Construct to Treat HIV-1 Infection NCT01734850	Calimmune, Inc.	Phase 1 / Phase 2
Completed	Pediatric Urgent Start of Highly Active Antiretroviral Treatment (HAART) NCT02063880	University of Washington	N/A
Completed	Functionality of Male Condoms With a Silicone Elastomer Vaginal RIng NCT01755741	International Partnership for Microbicides, Inc.	Phase 1
Completed	Improving Drug Adherence Among Adolescents in Uganda Using SMS Reminders NCT02128087	RAND	N/A
Completed	Improving Adherence Among HIV+ Rwandan Youth: A TI-CBTe Indigenous Leader Model NCT02464423	Hektoen Institute for Medical Research	N/A
Completed	Switching Undetectables to Selzentry NCT01866267	St. Hope Foundation	Phase 4
Unknown	Umbilical Cord Mesenchymal Stem Cells for Immune Reconstitution in HIV-infected Patients NCT01213186	Fu-Sheng Wang	Phase 2
Completed	A Phase 3, Open-label Study to Investigate the Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Gen NCT01783678	Gilead Sciences	Phase 3
Terminated	Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK- NCT01814722	Merck Sharp & Dohme LLC	—
Completed	Body Image in Youth With HIV NCT01673750	St. Jude Children's Research Hospital	—
Terminated	Brain Imaging for HIV-Associated Thinking and Mood Disorders NCT01692236	National Institutes of Health Clinical Center (CC)	—
Unknown	Mater-Bronx Rapid HIV Testing Project. NCT01778374	University College Dublin	N/A
Completed	Evaluating Accuracy, Impact, and Operational Challenges of GeneXpert Use for TB Case Finding Among HIV-infecte NCT02538952	Centers for Disease Control and Prevention	Phase 4
Completed	Dose Optimisation of Stavudine for the Treatment of HIV Infection NCT02670772	Willem Daniel Francois Venter	Phase 3
Completed	Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2 and 3 Hepatitis C Virus (HCV) and Hu NCT01667731	Gilead Sciences	Phase 3
Unknown	Tripterygium Wilfordii Hook F (TwHF) Treatment for Immune Non-responders With HIV-1 Infection NCT01666990	Beijing 302 Hospital	Phase 1 / Phase 2
Completed	HIV, Buprenorphine, and the Criminal Justice System NCT01550341	Yale University	N/A
Completed	Nevirapine Dosing in Neonates for Prophylaxis of Mother-to-Child-Transmission (MTCT) of HIV Infection NCT02166502	The Hospital for Sick Children	—
Unknown	Real-life Security and Efficacy of DAA-based Therapy in HCV/HIV-Coinfected Patients NCT02057003	Valme University Hospital	—
Terminated	Evaluation of Raltegravir Plus Maraviroc Therapy in Controlled HIV Patients Presenting With Lipohypertrophy NCT01420523	ANRS, Emerging Infectious Diseases	Phase 2
Completed	Platelets Study: Influence of the Antiretroviral Treatment on the Platelet Physiology During HIV Infection NCT02532348	Centre Hospitalier Universitaire de Saint Etienne	—
Completed	Maternal-fetal CD4 Microchimerism in HiV Exposed Newborns After Spontaneous Delivery and Cesarean Section NCT01450059	Johann Wolfgang Goethe University Hospital	—
Completed	A Safety Study Of A Single Vaginal Administration Of P2G12 Antibody In Healthy Female Subjects NCT01403792	University of Surrey	Phase 1
Completed	Development of Method of Fructose Identification in Urine to Detect the Viral Infection NCT01638312	Kaohsiung Medical University Chung-Ho Memorial Hospital	—
Completed	Single Ascending Dose (SAD)/Multiple Ascending Dose(MAD) Safety/Pharmacokinetic (PK) Study of KM-023 NCT01348516	Kainos Medicine Inc.	Phase 1
Completed	HIV and Drug Use in Georgian Women NCT01331460	University of North Carolina, Chapel Hill	N/A
Completed	Post-Exposure Prophylaxis in Health Care Workers NCT01234116	Henry Ford Health System	Phase 4
Completed	Pharmacokinetic Study of Raltegravir in Human Immunodeficiency Virus/Hepatitis C Virus (HIV/VHC) Coinfected Pa NCT01289951	Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal	Phase 1
Completed	Can Valacyclovir Attenuate Inflammation in Antiretroviral-Treated HIV-Infected Individuals With Herpes Simplex NCT01176409	University Health Network, Toronto	Phase 3
Completed	Alcohol Pharmacotherapy for HIV+ Prisoners NCT01077310	Yale University	N/A
Completed	Computer-Assisted Tailored Cue-card Health [CATCH] Study NCT01170741	RTI International	Phase 1
Completed	Tenofovir, Emtricitabine, Efavirenz and Atazanavir Pharmacokinetics in the Aging HIV-Infected Population NCT01180075	University of North Carolina, Chapel Hill	—
Completed	Notification of Donors With Positive Microbiology Markers NCT01050881	NHS Blood and Transplant	—
Completed	Europe-Africa Research Network for Evaluation of Second-line Therapy NCT00988039	Justine Boles	Phase 3
Completed	Pharmacokinetic Interactions Between an Herbal Medicine (African Potato) and Antiretroviral Agents (Lopinavir/ NCT01227590	University of California, San Francisco	Phase 1
Completed	Intervention of HIV, Drug Use and the Criminal Justice System in Malaysia NCT02396979	Yale University	Phase 4
Completed	Comparison of Concentration-time Course of Plasma and Intracellular Raltegravir in Healthy Volunteers NCT01027182	Changi General Hospital	Phase 1
Completed	Effect of Bednets and a Water Purification Device on HIV Disease Progression Among ART naïve Patients in Kenya NCT00914225	University of Washington	—
Terminated	A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-I NCT00798265	National Cancer Institute (NCI)	Phase 1
Completed	Pilot Study of a Raltegravir Based NRTI Sparing Regimen NCT00814879	Yale University	N/A
Unknown	An Open Label Pharmacokinetic, Safety And Efficacy Study Of Maraviroc In Combination With Background Therapy F NCT00791700	ViiV Healthcare	Phase 2
Withdrawn	Maraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis C NCT00782301	ViiV Healthcare	Phase 4
Terminated	Raltegravir (Isentress/MK-0518) and HIV-1 Infected CD4 Cells During Acute/Early HIV-1 NCT00781287	University of Washington	Phase 4
Completed	Fetal HIV Transmission Risk and Duration of Membrane Rupture NCT01616823	Unity Health Toronto	—
Completed	Omega-3 Supplementation in HIV Patients With Therapeutic Lifestyle Change Diet. NCT02537236	Instituto Mexicano del Seguro Social	Phase 3
Completed	A Study of Raltegravir in a Diverse Cohort of HIV-Infected Patients (0518-055) NCT00764946	Merck Sharp & Dohme LLC	Phase 3
Completed	Kaletra in Combination With Antiretroviral Agents NCT01076179	AbbVie (prior sponsor, Abbott)	—
Completed	Problems With Immune Recovery in the Gut Tissue NCT01460433	University of Minnesota	—
Completed	Tissue Drug Levels of HIV Medications NCT01490346	University of Minnesota	—
Completed	Mentor Mothers: A Sustainable Family Intervention in South African Townships NCT00972699	University of California, Los Angeles	Phase 2
Terminated	Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocyto NCT00678587	GlaxoSmithKline	Phase 3
Completed	Prospective Observational Epidemiologic Study of Maraviroc's Safety NCT00665561	ViiV Healthcare	—
Unknown	Adjusting Antiretroviral Therapy Dosage Using Therapeutic Drug Monitoring NCT00836212	University Hospital, Geneva	Phase 4
Completed	Treatment of Acute Hepatitis C Virus in HIV Co-Infection NCT00845676	University of California, San Francisco	Phase 4
Withdrawn	Safety And Efficacy Study Of CP-675,206 In HIV-Infected Patients NCT00488995	Pfizer	Phase 2
Completed	Treatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a Triple Combination Therapy With NCT00458302	Janssen-Cilag International NV	Phase 3
Completed	Efficacy Study of Different Laboratory Management Strategies and Drug Regimens in HIV-infected Children in Afr NCT02028676	Medical Research Council	Phase 4
Completed	Hepatic Safety of Currently Used Antiretroviral Regimens in Patients With Chronic Hepatitis Under Real Life Co NCT01908660	Valme University Hospital	—

Showing the 300 most recent trials. Use search for older records.